Scotia Capital’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.9M Buy
413,285
+109,800
+36% +$7.67M 0.14% 95
2025
Q1
$22.3M Buy
303,485
+71,688
+31% +$5.27M 0.12% 107
2024
Q4
$15.2M Sell
231,797
-181,745
-44% -$11.9M 0.08% 136
2024
Q3
$32.2M Buy
413,542
+39,787
+11% +$3.1M 0.17% 86
2024
Q2
$29.1M Buy
373,755
+72,161
+24% +$5.63M 0.17% 88
2024
Q1
$20.4M Buy
301,594
+138,340
+85% +$9.37M 0.12% 107
2023
Q4
$11M Buy
163,254
+26,639
+19% +$1.79M 0.07% 155
2023
Q3
$9.25M Buy
136,615
+13,628
+11% +$923K 0.07% 160
2023
Q2
$8.8M Buy
122,987
+11,095
+10% +$794K 0.06% 165
2023
Q1
$7.77M Sell
111,892
-4,010
-3% -$278K 0.06% 178
2022
Q4
$7.86M Sell
115,902
-7,130
-6% -$483K 0.06% 170
2022
Q3
$6.75M Buy
123,032
+20,840
+20% +$1.14M 0.05% 185
2022
Q2
$6.75M Buy
102,192
+12,247
+14% +$809K 0.05% 189
2022
Q1
$5.97M Buy
89,945
+8,972
+11% +$595K 0.04% 222
2021
Q4
$4.72M Buy
80,973
+18,213
+29% +$1.06M 0.03% 263
2021
Q3
$3.77M Buy
62,760
+48,750
+348% +$2.93M 0.03% 276
2021
Q2
$839K Sell
14,010
-4,140
-23% -$248K 0.01% 535
2021
Q1
$902K Sell
18,150
-2,674
-13% -$133K 0.01% 503
2020
Q4
$1.04M Buy
20,824
+1,937
+10% +$96.8K 0.01% 427
2020
Q3
$1.04M Buy
+18,887
New +$1.04M 0.01% 384
2020
Q2
Sell
-11,262
Closed -$503K 643
2020
Q1
$503K Buy
11,262
+1,095
+11% +$48.9K 0.01% 434
2019
Q4
$507K Buy
10,167
+200
+2% +$9.97K 0.01% 509
2019
Q3
$444K Sell
9,967
-135
-1% -$6.01K 0.01% 542
2019
Q2
$417K Buy
10,102
+135
+1% +$5.57K 0.01% 549
2019
Q1
$403K Buy
9,967
+4,261
+75% +$172K 0.01% 532
2018
Q4
$217K Sell
5,706
-780
-12% -$29.7K ﹤0.01% 589
2018
Q3
$257K Buy
6,486
+670
+12% +$26.5K ﹤0.01% 635
2018
Q2
$201K Hold
5,816
﹤0.01% 627
2018
Q1
$203K Buy
+5,816
New +$203K ﹤0.01% 653